BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruys AT, Tanis PJ, Nagtegaal ID, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM. Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol. 2011;18:1932-1938. [PMID: 21347794 DOI: 10.1245/s10434-010-1526-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Shinohara N, Abe T. Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma. Int J Urol 2015;22:888-97. [DOI: 10.1111/iju.12858] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
2 Ljungberg B. The Role of Metastasectomy in Renal Cell Carcinoma in the Era of Targeted Therapy. Curr Urol Rep 2013;14:19-25. [DOI: 10.1007/s11934-012-0293-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
3 Kim DY, Karam JA, Wood CG. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. World J Urol 2014;32:631-42. [DOI: 10.1007/s00345-014-1293-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
4 Liu C, Tao T, Xu B, Lu K, Zhang L, Jiang L, Chen S, Liu D, Zhang X, Cao N, Chen M. BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1. Oncol Lett 2015;10:619-24. [PMID: 26622543 DOI: 10.3892/ol.2015.3293] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
5 Hau HM, Thalmann F, Lübbert C, Morgul MH, Schmelzle M, Atanasov G, Benzing C, Lange U, Ascherl R, Ganzer R, Uhlmann D, Tautenhahn HM, Wiltberger G, Bartels M. The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy. BMC Surg 2016;16:49. [PMID: 27444582 DOI: 10.1186/s12893-016-0163-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Tan MC, Jarnagin WR. Surgical management of non-colorectal hepatic metastasis: Non-Colorectal Metastatectomy. J Surg Oncol 2014;109:8-13. [DOI: 10.1002/jso.23462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sellner F. Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations. Front Oncol 2020;10:709. [PMID: 32547940 DOI: 10.3389/fonc.2020.00709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184-190. [PMID: 22558019 DOI: 10.7150/jca.4456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
9 Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford). 2012;14:532-538. [PMID: 22762401 DOI: 10.1111/j.1477-2574.2012.00495.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
10 Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. Urology 2017;99:155-61. [DOI: 10.1016/j.urology.2016.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
11 Josephides E, Rodriguez-Vida A, Galazi M, Chowdhury S, Suder A. The role of metastasectomy in renal cell carcinoma. Expert Rev Anticancer Ther 2013;13:1363-71. [PMID: 24236818 DOI: 10.1586/14737140.2013.856762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Grimes NG, Devlin JM, Dunne DF, Jones RP, Poston GJ, Fenwick SW, Malik HZ. A systematic review of the role of hepatectomy in the management of metastatic renal cell carcinoma. Eur J Surg Oncol. 2014;40:1622-1628. [PMID: 25228053 DOI: 10.1016/j.ejso.2014.08.472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Chaves KC, Peron JP, Chammas R, Turaça LT, Pesquero JB, Braga MS, Foguer K, Schor N, Bellini MH. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. Cancer Gene Ther. 2012;19:558-565. [PMID: 22699868 DOI: 10.1038/cgt.2012.32] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Russell CM, Espiritu PN, Kassouf W, Schwaab T, Buethe DD, Dhilon J, Sexton WJ, Poch M, Powsang JM, Tanguay S, Nayan M, Alsaadi H, Hanzly MI, Spiess PE. Surgical Outcomes in the Management of Isolated Nodal Recurrences: A Multicenter, International Retrospective Cohort. Journal of Urology 2014;192:350-6. [DOI: 10.1016/j.juro.2014.02.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
16 de Ridder J, de Wilt JH, Simmer F, Overbeek L, Lemmens V, Nagtegaal I. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget 2016;7:55368-76. [PMID: 27421135 DOI: 10.18632/oncotarget.10552] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 12.5] [Reference Citation Analysis]
17 Omid S, Abufaraj M, Remzi M. Metastasectomy in patients with renal cell carcinoma: when and how? Curr Opin Urol 2020;30:602-9. [PMID: 32464043 DOI: 10.1097/MOU.0000000000000768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 González J, Gaynor JJ, Alameddine M, Esteban M, Ciancio G. Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma. Expert Rev Anticancer Ther 2018;18:237-50. [PMID: 29353520 DOI: 10.1080/14737140.2018.1431530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
19 Beetz O, Söffker R, Cammann S, Oldhafer F, Vondran FWR, Imkamp F, Klempnauer J, Kleine M. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Langenbecks Arch Surg 2020;405:97-106. [PMID: 31938833 DOI: 10.1007/s00423-019-01852-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Achkar T, Maranchie JK, Appleman LJ. Metastasectomy in Advanced Renal Cell Carcinoma: A Systematic Review. KCA 2019;3:31-40. [DOI: 10.3233/kca-180042] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Thomas AZ, Adibi M, Borregales LD, Wood CG, Karam JA. Role of metastasectomy in metastatic renal cell carcinoma. Current Opinion in Urology 2015;25:381-9. [DOI: 10.1097/mou.0000000000000196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
22 Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, Patel SG, Downey RJ, Strong VE, Russo P. Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites. J Surg Oncol 2016;114:375-9. [PMID: 27338155 DOI: 10.1002/jso.24327] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
23 Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg. 2014;399:989-1000. [PMID: 25148767 DOI: 10.1007/s00423-014-1241-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
24 Ouzaid I, Capitanio U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, Van Poppel H, Bensalah K; Young Academic Urologists Kidney Cancer Working Group of the European Association of Urology. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. Eur Urol Oncol. 2019;2:141-149. [PMID: 31017089 DOI: 10.1016/j.euo.2018.08.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
25 Pikoulis E, Margonis GA, Antoniou E. Surgical Management of Renal Cell Cancer Liver Metastases. Scand J Surg 2016;105:263-8. [PMID: 26929295 DOI: 10.1177/1457496916630644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Geisel D, Collettini F, Denecke T, Grieser C, Flörcken A, Wust P, Hamm B, Gebauer B. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series. World J Urol 2013;31:1525-30. [PMID: 23132612 DOI: 10.1007/s00345-012-0981-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
27 Pittman ME, Yantiss RK. Frozen Sections of the Liver. Surg Pathol Clin 2018;11:453-66. [PMID: 29751885 DOI: 10.1016/j.path.2018.02.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Araújo WF, Naves MA, Ravanini JN, Schor N, Teixeira VP. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice. Urol Oncol 2015;33:389.e1-7. [PMID: 25595575 DOI: 10.1016/j.urolonc.2014.11.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
29 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 9(5): 242-251 [PMID: 28261381 DOI: 10.4254/wjh.v9.i5.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
30 Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77 [PMID: 28255428 DOI: 10.4251/wjgo.v9.i2.70] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
31 Nagaraja H, Srivatsa N, Hemalatha S, Shweta S, Raghunath SK. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma. Indian J Surg Oncol 2018;9:105-9. [PMID: 29563747 DOI: 10.1007/s13193-018-0722-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Parisi A, Trastulli S, Ricci F, Regina R, Cirocchi R, Grassi V, Gemini A, Pironi D, D'andrea V, Santoro A, Desiderio J. Analysis of long-term results after liver surgery for metastases from colorectal and non-colorectal tumors: A retrospective cohort study. International Journal of Surgery 2016;30:25-30. [DOI: 10.1016/j.ijsu.2016.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Psutka SP, Master VA. Role of metastasis-directed treatment in kidney cancer. Cancer. 2018;124:3641-3655. [PMID: 29689599 DOI: 10.1002/cncr.31341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
34 Martel G, Bertens KA, Canil C. Surgical Management of Genitourinary Cancer Liver Metastases. Surg Oncol Clin N Am 2021;30:89-102. [PMID: 33220811 DOI: 10.1016/j.soc.2020.08.003] [Reference Citation Analysis]
35 Kulik U, Lehner F, Bektas H, Klempnauer J. Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications. Viszeralmedizin 2015;31:394-8. [PMID: 26889142 DOI: 10.1159/000439419] [Reference Citation Analysis]
36 Chaves KCB, Turaça LT, Pesquero JB, Mennecier G, Dagli MLZ, Chammas R, Schor N, Bellini MH. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy. Biomedicine & Pharmacotherapy 2012;66:464-8. [DOI: 10.1016/j.biopha.2012.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
37 Pinotti E, Montuori M, Giani A, Uggeri F, Garancini M, Gianotti L, Romano F. Surgical treatment of liver metastases from kidney cancer: a systematic review. ANZ J Surg. 2019;89:32-37. [PMID: 30685878 DOI: 10.1111/ans.15000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
38 Kis B, Shah J, Choi J, El-Haddad G, Sweeney J, Biebel B, Mellon E, Frakes JM, Hoffe SE, Fishman MN, Shridhar R. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. J Vasc Interv Radiol 2017;28:254-9. [PMID: 27955832 DOI: 10.1016/j.jvir.2016.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
39 De Raffele E, Mirarchi M, Casadei R, Ricci C, Brunocilla E, Minni F. Twenty-year survival after iterative surgery for metastatic renal cell carcinoma: A case report and review of literature. World J Clin Cases 2020; 8(19): 4450-4465 [PMID: 33083404 DOI: 10.12998/wjcc.v8.i19.4450] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]